Identification of a CD36-related thrombospondin 1-binding domain in HIV- 1 envelope glycoprotein gp120: Relationship to HIV-1-specific inhibitory factors in human saliva

Journal of Experimental Medicine

Volumn 187, Issue 1, 1998, Pages 25-35

  Crombie, René ^a   Silverstein, Roy L ^a   MacLow, Clarinda ^a   Pearce, S Frieda A ^a   Nachman, Ralph L ^a   Laurence, Jeffrey ^a,b  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; CD4 ANTIGEN; CYSTEINE; DISULFIDE; GLYCOPROTEIN GP 120; HYBRID PROTEIN; PROPERDIN; RECEPTOR; RECOMBINANT PROTEIN; THROMBOSPONDIN 1;

ARTICLE; BINDING SITE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; PRIORITY JOURNAL; SALIVA; VIRUS INFECTIVITY;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD36; ANTIGENS, CD4; BINDING SITES; GENES, ENV; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE MAPPING; SALIVA; SEQUENCE HOMOLOGY, AMINO ACID; THROMBOSPONDIN 1;

EID: 0031983724     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.1.25     Document Type: Article

References (73)

1. Ho, D.D., B.S. Byington, K.T. Schooley, T.R. Rota, and M.S. Hirsch. 1985. Infrequencey of isolation of HTLV-III virus from saliva in AIDS. Ney Engl. J. Med. 313:1606.
2. Groopman, J.R., S.Z. Salahuddin, M.G. Sarngadharan, P.D. Markham, M. Gonda, M. Sliski, and R.C. Gallo. 1994. HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS. Science. 226: 447-449.
3. Liuzzi, G.A., A. Chirianni, M. Clementi, P. Bagnareni, A. Valenza, P.T. Catello, and M. Piazza. 1996. Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS. 10:F10-F56.
4. CDC. 1988. Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other blood-borne pathogens in healthcare settings. Morb. Mortal. Wkly. Rep. 37:377-388.
5. Klein, K.S., J.A. Phelan, K. Freeman, C. Schable, G.H. Friedland, N. Trieger, and N.H. Steigbigel. 1988. Low occupational risk of human immunodeficiencey virus infection among dental professionals. New Engl. J. Med. 318:86-90.
6. Fultz, P.N. 1986. Components of saliva inactivate human immunodeficiency virus. Lancet. 2:1215.
7. Remis, R.S., M.S. Rossignol, and M.A. Kane. 1987. Hepatitis B infection in a day school for mentally retarded students: transmission from students to staff. Am. J. Public Health. 77: 1183-1186.
8. Achiron, A., O. Pinhas-Hamiel, Y. Barak, L. Doll, D. Offen, R. Djaldetti, G. Frankel, and B. Shohat. 1996. Detection of proviral-human T-cell lymphotropic virus Type I DNA in mouthwash samples of HAM/TSP patients and HTLV-I carners. Arch. Virol. 141:147-153.
9. Lercke, N.W., K.G. Osborn, P.A. Marx, S. Prahalaha, D.H. Maul, L.J. Lowenskine, R.J. Munn, R.V. Hennekson, C.O. Arthur, K. V. Gilden, et al. 1986. Inapparent carrier of simian acquired immune deficiency type D retrovirus and disease transmission with saliva. J. Natl. Cancer Inst. 77:489-495.
10. Malamud, D., C. Davis, P. Berthold, E. Roth, and H. Friedman. 1993. Human submandibular saliva aggregates HIV. AIDS Res. Hum. Retroviruses 9:633-637.
11. Fox, P.C., A. Wolff, C.-F. Yen, J.C. Atkinson, and B.J. Baum. 1988. Saliva inhibits HIV-1 infectivity. J. Am. Dent. Assoc. 116:635-637.
12. Alsip, G.R., Y. Enchy, C.V. Sumaya, and K.M. Boswell. 19SH. Increased Epstein-Barr virus DNA in oropharygeal secrecions from patients with AIDS. AIDS-related complex, or asymptomatic human immunodeficiency virus infections. J. Infect. Dis. 157:1072-1070.
13. Scholes, A., N. Beeching, P. Carey, M. Martin, and C. Hart. 1993. Oral shedding of CMV and HSV in relation to HIV disease. IXth International Conference AIDS. Berlin, June 6-11. PO-B18-1801 (Abstr.)
14. CDC. 1986. Recommendations for preventing possible transmission of human T-lymphotropic virus type III/ lymphadenopathy-associated virus from tears. Morb. Mortal. Wkly. Rep. 34:533-534.
15. Mostad, S.B., and J.K. Kreiss. 1996. Shedding of HIV in the genital tract. AIDS. 10:1305-1315.
16. Yolken, R.H., S. Li, J. Perman, and R. Viscidi. 1991. Persistent diarrhea and fecal shedding of retroviral nucleic acids in children infected with human immunodeficiency virus. J. Infect. Dis. 164:61-66.
17. VandePerre, P., A. Simonon, D.-G. Hitimana, F. Dabis, P. Msellati, B. Mukamababo, J.-P. Butera, C.V. Goethem, E. Karita, and P. Lepage. 1993. Infective and anti-infective properties of breast milk from HIV-1 infected women. Lancet. 341. 914-918.
18. Fox, P.C., A. Wolff, C.-F. Yeh, J.C. Atkinson, and B.J. Baum. 1989. Salivary inhibition of HIV-1 intectivity: functional properties and distribution in men. women and children. J. Am. Dent. Assoc. 118:709-711.
19. Archibald, D.W., and D.A. Cole. 1990. In vitro inhibition of HIV-1 infectivity by human salivas. AIDS Res. Hum. Retroviruses. 6:1425-1432.
20. McNeely, T.B., M. Dealy, D.J. Dripps, J.M. Orenstein, S.P. Eisenberg, and S.M. Wahl. 1995. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodedficiency virus 1 activity in vitro. J. Clin. Invest. 96:456-464.
21. Malamud, D., and H.M. Freidman. 1993. HIV in the oral cavity: virus, viral inhibitory activity, and antibodies: a review. Crit. Rev. Oral. Biol. Med. 4:461-466.
22. Amory, J., N. Martin, J. Levy, and D. Wara. 1992. The large molecular weight glycoprotein MG1, J component of human saliva, inhibits HIV-1 infectivity. Clin. Res. 40:51A.
23. Yeh, C.-K., U. Hardelman. P.C. Fox, and B.J. Baum. 1992. Further studies of salivary inhibition of HIV-1 infectivity. J. Acquired Immune Defic. Syndr. 5:898-903.
24. Bergey, E.J., M.-I. Cho, B.M. Blumberg, M.-L. Hammarskjold, D. Rekosh, L.J. Epstein, and M.J. Levine. 1994. Interaction ot HIV-1 and human salivary mucins. J. Acquired Immune Defic. Syndr. 7:995-1002.
25. Phillips, J.N., C. Qureshi, C. Barr, and D.R. Henrard. 1994. Low level of cell-free virus detected at high frequency in saliva from HIV-1 infected indidviduals. AIDS. 8:1011-1012.
26. Levine, J.M., M.S. Keddy, L.A. Tabak, R.E. Loomis, E.J. Bergey, P.C. Jones, R.E. Cohen, M.W. Stinson, and I. AlHashimi. 1987. Structural aspects of salivary-glycoproteins. J. Dent. Res. 66:436-441.
27. Uu. M., J.A. Turpm. C.A. Schacfter. L. Graham, and R.W. Buckheit. Jr., and W.Ci. Rice. 199.5. Secretory leukocyte protease inhibitor (SLPI-) does not effectively inhibit HIV-I replication. 35th International Conference on Antimicrobial Agents and Chemotherapy. San Francisco. CA. September 17-20. 1142 (Abstr.)
28. Su. H.L., and RJ. Boackle. 1991. Interaction of the envelope glycoprotem of human immunodeficiency virus with CIq and fibronectin under conditions present in saliva. .Wo/. InIIHHJIO/. 28:811-817.
29. Bormtem, P. 1992. Thrombospondins: structure and regulation of expression. f-'ASEB (Fai. Am. Sec. E\p. Rial./ J. (,: 3222-3229.
30. Lahav. J., editor. 1993. Thronibospondin. CRC Press. Boc.i Raton. FL. pp. 1-298.
31. Lahav. J. 1993. The functions of thrombospondin and its involvement in physiology and pathophysiology. Biochim. Kophys. Acta. 1182:1-14.
32. Sinnis, P., T.E. Willnow, M.R.S. Bnones. J. Herz, and V. Nussenzweig. 1996. Remnant Hpoproteins inhibit malaria sporozoite invasion of hepatorytes.J. I2xp. Med. 184:945-954.
33. Taraboletti. G., D. Roberts, L.L. Liotta, and R. Gavazzi. 1990. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor./ Cell BmI. 1 1 1:765-772.
34. Pearce, S.F.A., J. Wu, and R.L. Silverstem. 1995. Recombinant GST/CD36 fusion proteins define a thrombospondin binding domain: evidence for a single calcium-dependent binding site on CD36J. B/o/. OH-IW. 270:2981-2986.
35. Crombie, R., and R.L. Silverstem. 1997. Lysosomal integral membrane protein LIMP II binds thrombospondin-1: structure-function homology with the cell adhesion molecule CD36 defines a conserved recognition motif. /. BhI. C/H-III. In press.
36. Ivanhoff. L.A.,}.W. Dubay. J.F. Morns. SJ. Roberts, L. Gutshall, EJ. Sternberg, E. Hunter, TJ. Matthews, and S.R. Petteway. 1992. V3 loop region of the HlV-I envelope protein is essential for virus intectivity. I ïro/osjy. 187:423-132.
37. Worley. K.C., B.A. Wiese, and R.F. Smith. 1995. BEAUTY: an enhanced BLAST-based search tool that integrates multiple biological information resources into sequence similarity search results. Genome Res. 5:173-184.
38. Smith, R.F., and T.F. Smith. 1992. Pattern-induced multisequence alignment (PlMA) algorithm employing secondary structure-dependent gap penalties for comparative protein modelling. Protein Eng. 5:35-41.
39. Bairoch. A. 1993. The PROSITE dictionary of sites and patterns, its current status. Xuclcic Acids Rc.-. 21:3097-3103.
40. Silverstem. R.L., L.L.K. Leung. P.C. Harpt-1. and R.L. Nachman. 1985. Platelet thrombospondin forms a tnmolecular complex with plasminogen and histidme-rich glycoprotem. /. Oiii. Imvst. 75:2(165-2073.
41. Silverstein. R.L., and R.L. Nachman. 1987. Thrombospondin binds to monocytes-macrophages and mediates plateletmonocyte adhesion. J. Clin. Iinvst. 79:867-874.
42. Pearce. S.F.A., J. Wu. and RT. Silverstem. 1994. A carboxy terminal truncation mutant of CD36 is secreted and binds thrombospondin: evidence for a single transmembrane domain. Blood. 84:384-389.
43. Frangioni. J.V., and B.G. Neel. 1993. Solubilization and purification of enzymatically active gJutathione-S-rransferase (pGEX) fusion proteins. Audi. Bioclicm. 21(1:179-187.
44. Silverstem, R.L., L.L.K. Leung. and R.L. Nachman. I1WCx Thrombospondin: a versatile multitunction.il glycoprorein. Artïriofclenvis. 6:245-253.
45. MacGregor. J.L., B. Catimel. S. Parmentier. F. Clezardin. M. Dechavanne. and L.L. Leung. 1989. Rapid purification and partial characterization of human platelet glycoprotein 11 Ib. J. BwI. CIiCiIi. 264:501-50
46. Hajjar. K.A., I). Gavish, J.L. Breslow, and R.L. Nachman. 1989. Lipoprotem(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Xarnrc. 339:303-305.
47. Smith, D.J., M.A. Taubman. and W.F. King. 19H7. Immunological features of minor salivary gland saliva. /. CVi/;. Imiminol. 7:449-454.
48. Laurence. J., S.M. Fnedman. E.K. Chartash. M.K. Grow, and D.N. Posnett. 1989. Human immunodeficiency virus infection of helper T-cell clones: early proliferative defects despite intact antigen-specific recognition and interleukm 4 secretion. J. Clni. Invest. 83:1843-1848.
49. Laurence, J., A. Sanders, E. Early, and J.E. Salmon. 1990. Human immunodeficiency virus infection ot monocytes: relationship to Fc-gamma receptors and antibody-dependent viral enhancement. Immunology. 70:338-343.
50. Vega, M.A., B. Segui-Real, J.A. Garcia, C. Gales, F. Rodriguez,J. Vanderkerckhove, and I.V. Sandoval. 1991. Gloning, sequencing, and expression of a cDNA encoding the rat LIMP II. a novel 74-kDa lysosomal membrane protein related to the surface adhesion protein CD36. J. Biol. Cliciu. 266:16818-16824.
51. Calvo. D., J. Dopazo, and M.A. Vega. 1995. The CD36, GLA-I (CD36L1), and LIMF II (CD36L2) gene family: cellular distribution, chromosomal location, and genetic evolution. Cenomicf. 25:100-106.
52. Asch, A.S.,J. Tepler. S. Silbiger, and R.L. Nachman. 1991. Cellular attachment to thrombospondin: cooperative interactions between receptor systems. J. Biol. Client. 266:1740-1745.
53. Catimel, B., L. Leung. H. clGhissasi, N. Mercier, and J. McGregor. 1992. Human platelet glycoprotem UIb binds to thrombospondin fragments bearing the G-termmal region, and/or the type I repeats (CSVTGG motif), hut not to the N-terminal hepann-binding region. Bioclicm.J. 284:231-236.
54. Li. W.X., and L.L. Leung. 1993. Identification of SVTOG in thrombospondin as the conformation-dependent, high affinity binding site for its receptor, CD36. J. Biol. Client. 268: 16179-16184.
55. Varam.J., L. Stoolman, T. Wang, L. Schuger, C. Flippen, M. Dame. K.J. Johnson. R.F. Todd III, U.S. Ryan, and F.A. Ward. 1991. Thrombospondin production and thrombospondm-mediated adhesion in U937 cells. L.\p. Cell. Res. 195:177-182.
56. Qureshi, M.N., B. Joshi. I. Hewlett. I). Henrard, Z. Qm, and C.E. Barr. 1994. Prevalence of HIV-I proviral UNA an virion-associated RNA in saliva. J. Dein. Res. 73:2564A. (Abstr.).
57. Moore. U.E., C.M. Flaitz, D.H. Copenhaver, C.M. Nichols. C,.1X Kalmaz.J.IX Bresman. M.W. Gioyd. D.F. Lynch. B.S. Frabhakar, and S. Baron. 1993. HIV recovery from saliva before and after dental treatment: inhibitors may have a critical role in viral inactivation.J. Am. Dent. AîSOC. 124:67-74.
58. Fox. F.G. 1991. Saliva and salivary gland alterations in HIV infection. J. Am. UCH/. ,4.-1SiIf. 122:46-W.
59. Da\ves. J.P., P. Clezardin. and O.A. VrMt. 19X7. Thrombospondin in milk, other breast secretions and breast tissue. Scni. Tliwinb. Hcimvtasii. 13:378-384.
60. Guay. L.A., D.L. Horn. F. Mmiro. E.M. Piwowar. S. Kabengera. J. Parsons, C. Ndug\va. L. Marum. K. Olness. P. Kataaha, and J.B. Jackson. 1996. Detection of human immunodeficiency virus type 1 (HIV-I) DNA and p24 antigen in breast milk of HIV-I-infected Ugandan women and vertical transmission. Pediatrics. 98:438-444.
61. Tynelius-Bratthall, G., D. Ericson. and M.M. Araujo. 1986. Fibronectin in saliva and gingival crevices. J. Perioiioiiul Rc<. 21:563-568.
62. Torre, I)., M. lssi. C. Sampietro. G.P. Fior, G. Chelazzi. and G. Ferraro. 1990. Plasma fibronectin concentrations in patients \vith human immunodeficiency vims infection. J. CHn. Pathol. 43:560-562.
63. Ushijima. H., S. Unten, and H. Hormen. 1992. Effect of serum components on syncytiurn formation and virus production by cells infected with human immunodeficiency viruses in vitro. AIDS Ra. Hum. Rctroi'imscs. 8:513-52o.
64. Banllan. G., A. Holmes. R. Gendelman. L. Buonaguro. R.C. Gallo, and B. Ensoli. 1993. The RGD motif and the integrm receptors are involved in the vascular cell growth and adhesive properties of extracellular HIV-I Tat protein. J. AIDS. 6:688A (Abstr.).
65. Roberts. D.D., N. Guo. PJ. Browning. V.S. Zabrenetzky, J.K. Inman. and H.C. Krutzsch. 1995. Modulation of tumor growth in vitro and in vivo by stable analogs of thrombospondin peptides. AIDS Res. Hum. Reiroi'imses. 11(51):40 (Abstr.).
66. Baba, N., E. DeClercq, D. Schols, R. Pauwels. R. Snoeck, C. VanBoeckel, G. VanDedem, N. Kraaijeveld, P. Hobbelen. H. Ottenheijm, and F.D. Hollander. 1990. Novel sulfated polysacchandes: dissociation of anti-human immunodeficiency virus activity from anti-thrombm activity. J. Inject. Dis. 161:208-213.
67. Stoiber, H.R., R. Schneider, J. Janatova, and M.P. Dierich. 1995. Human complement proteins C3b, C4b, factor H and properdm react with specific sites in gp!20 and gp41, the envelope proteins of HIV-1. Immutiobiology. 193:98-1 13.
68. Kowalski, M., J. Potz, L. Basiripour, T. Dorfman, W.C. Goh, E. Terwilhger, A. Dayton. C. Rosen, W. Haseltme, and J. Sodroski. 1987. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. .SaCHfC. 237:1351-1355.
69. Nagashunmugam. T., H.M. Friedman. C. Davis. S. Kennedy, L.T. Goldstein, and D. Malamud. 1997. Human submandibular saliva specifically inhibits HIV type 1. AIDS Res. Hum. Rctroi'imses. 13:371-376.
70. LaI. K., J.J. Pollock. R.P. Santarpia III, H.M. Heller. H.W. Kaufman, J. Fuhrer, and R.T. Steigbigel. 1992. Pilot study comparing the salivary canonic protein concentrations in healthy adults and AIDS patients: correlation svith antifungal activity.,/. AIDS. 5:904-914.
71. Mosher. D.F. 1990. Physiology of thrombospondin. Ann. RCI: Mai. 41:85-97.
72. Adams, S.L., M. Pacific!, D. Boettiger, and K.M. Pallante. 1987. Modulation of fibronectin gene expression in chondrocytes by viral transformation and substrate attachment. J. Cell. oio/. 105:483-488.
73. Madigan. A., and P. Murray. 1994. Caries and cnogenic flora in HIV-positive children versus unmfected children. J, Dent. Ro. 73:189KA. (Abstr).